Johnson & Johnson(JNJ) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

JNJ Johnson & Johnson

Watchlist

164.250
+1.410+0.87%

Close Mar 18 16:00 ET

164.250
0.0000.00%

Post 20:01 ET

395.45BMarket Cap28.37P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Gilead, GSK Could Be Impacted by Potential HHS HIV Prevention Cuts
Seeking Alpha17:34 ET
Trump Administration Follows Biden in Defending 340B Drug-discount Program
Seeking Alpha15:22 ET
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
Benzinga14:22 ET
Green Gives Way to Red on Gossamer Macro Expectations: Live Stock News
Kevin TraversMar 18 10:32 ET
SA Charts: How Are M&A Deals Shaping up at the Start of 2025?
Seeking AlphaMar 18 09:05 ET
Johnson & Johnson (JNJ.US) has initiated a phase three clinical trial for an oral cyclic peptide targeting IL-23R for psoriatic arthritis.
The third phase clinical trial plans to enroll 540 patients with Silver psoriasis arthritis, expected to be completed preliminarily by 2026.
Zhitong FinanceMar 18 09:03 ET

Comments

Cow Moo-ney

13 hours ago

Low volume

The market had rallied for 2 consecutive days but I’m not quite convinced by it due to the lack of strength and volume.
We had relatively low volume last Friday and yesterday (Monday). This means not a lot of buyers are stepping in, while sellers took a temporary pause.
I’m guessing many are waiting for Wed’s FOMC meeting. Jerome Powell’s press conference is key.
$Tesla (TSLA.US)$ $Apple (AAPL.US)$ $NVIDIA (NVDA.US)$ $Microsoft (MSFT.US)$ $Meta Platforms (META.US)$ $Alphabet-A (GOOGL.US)$ $Amazon (AMZN.US)$ $Palantir (PLTR.US)$ $Vanguard S&P 500 ETF (VOO.US)$ $SPDR S&P 500 ETF (SPY.US)$ $Invesco QQQ Trust (QQQ.US)$ $Palantir (PLTR.US)$ $Morgan Stanley (MS.US)$ $Johnson & Johnson (JNJ.US)$ $Walmart (WMT.US)$ $Bank of America (BAC.US)$ $Disney (DIS.US)$

https://youtu.be/QMs2e77yT9c

From YouTube

Fed’s March rate decision nears: Market pivot ahead?

Teddy123

14 hours ago

Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now receiv

$Johnson & Johnson (JNJ.US)$
Breakthrough Sjögren's Drug Achieves Rare FDA Double Designation with 70% Efficacy

RIPPER

Mar 14 23:11

Still think JNJ should breakdown to a minimum of $155. Head and shoulders pattern should break trendline, a $7 range from the current neckline. First target is 159, second target 152.

$Johnson & Johnson (JNJ.US)$ Like always buy time, 4/17 or 5/16 expiration PUTS 160 or 155 strike. My gut is telling me we should be hitting the 155 within the next week, but you never know……..
Disclaimer: I’m on a win streak, like never before…. like I keep telling myself, IM WAYYYY OVERDUE being wrong. Just s...

ひな☆彡 SOXL ♡

Mar 14 21:55

I added

$JNJ 250411 162.50P$
bought this again. lets see..

10baggerbamm

Mar 13 21:17

$Johnson & Johnson (JNJ.US)$ $BEIERSDORF AG UNSP ADR EACH REPR 0.20 ORD (BDRFY.US)$
I finally figured it out, they don't like skin cancer and they're short these companies that make suntan oil. that's what's been going on and I finally figured it out they want the stocks to go down because they figure if everybody adopts their approach and covers up like this these stocks will collapse because a lot of their sales come from suntan oil.

JNJ Johnson & Johnson

Trade Overview

Capital Trend

News

Comments

Trending Stocks